UK markets open in 4 hours 23 minutes
  • NIKKEI 225

    28,925.74
    +50.85 (+0.18%)
     
  • HANG SENG

    28,960.04
    +142.97 (+0.50%)
     
  • CRUDE OIL

    73.09
    +0.01 (+0.01%)
     
  • GOLD FUTURES

    1,776.80
    -6.60 (-0.37%)
     
  • DOW

    33,874.24
    -71.34 (-0.21%)
     
  • BTC-GBP

    23,227.50
    -1,219.97 (-4.99%)
     
  • CMC Crypto 200

    779.07
    -31.13 (-3.84%)
     
  • ^IXIC

    14,271.73
    +18.46 (+0.13%)
     
  • ^FTAS

    4,039.40
    -7.47 (-0.18%)
     

Portfolio Update

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The Board notes the announcement made yesterday by Arecor Therapeutics plc ("Arecor"), one of the Company's investee companies, to seek to have its shares admitted to trading on AIM, RNS No: 6941Y.

Assuming the placing and admission takes place at a share price in the range indicated, the Company's value of its investment in Arecor is anticipated to increase. The Board intends to make a further announcement that will quantify that impact, after the admission has taken place.

For further information contact:

Oxford Technology Management

Lucius Cary

01865 784466


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting